Showing results (41-50 of 160) with videos related to
Sort By:
Pageof 16
The Review of Diabetic Studies : RDS|June 28, 2013
Clinical potential of antigen-specific therapies in type 1 diabetesKen T Coppieters, Birgit Sehested Hansen, Matthias G von HerrathJournal of Immunology (Baltimore, Md. : 1950)|January 5, 2002
Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic choriomeningitis virus) autoimmune diabetes without impeding viral clearanceMatthias G von Herrath, Bryan Coon, Tom Wolfe, et al.Frontiers in Immunology|January 22, 2016
Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 DiabetesMinh N Pham, Matthias G von Herrath, Jose Luis VelaDiabetes|March 31, 2007
Minimal impact of a de novo-expressed beta-cell autoantigen on spontaneous diabetes development in NOD miceMarianne M Martinic, Amy E Juedes, Damien Bresson, et al.Journal of Autoimmunity|September 1, 2009
Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?Urs Christen, Edith Hintermann, Martin Holdener, et al.Physiological Reviews|January 21, 2011
Type 1 diabetes: etiology, immunology, and therapeutic strategiesTom L van Belle, Ken T Coppieters, Matthias G von HerrathAutoimmunity Reviews|August 6, 2016
The viral paradigm in type 1 diabetes: Who are the main suspects?Teresa Rodriguez-Calvo, Somayeh Sabouri, Florence Anquetil, et al.Immunity|May 15, 2012
Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic isletsTom L Van Belle, Stefan Nierkens, Ramon Arens, et al.Journal of Autoimmunity|December 17, 2009
Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatmentTom L Van Belle, Therese Juntti, Jeanette Liao, et al.Clinical Microbiology Reviews|January 19, 2006
Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune diseaseRobert S Fujinami, Matthias G von Herrath, Urs Christen, et al.Pageof 16